Trial intelligence / Profile preview

PCI vs Optimal Medical Therapy for Quality of Life in CTO

NCT02964975Phase 4Completed

Sponsor
University Clinical Center of Serbia
Start
Sep 2015
Primary completion
Nov 2017
Countries
1
01

Overview

Phase 4, randomised, open-label trial (2 arms), sponsored by University Clinical Center of Serbia. Primary endpoint: Seattle Angina Questionnaire at 6 months. Started Sep 2015; status: completed.

Beyond the preview

Go deeper on NCT02964975.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02964975.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call